Inogen reported $43.77M in Selling and Administration Expenses for its fiscal quarter ending in June of 2024.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 36.57M 3.79M Sep/2025
Artivion USD 55.75M 4.54M Dec/2025
AtriCure USD 82.88M 319K Sep/2026
Baxter International USD 730M 5M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Boston Scientific USD 1.68B 120M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 560.9M 300K Sep/2026
Globus Medical USD 288.47M 1.65M Sep/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 350.7M 5.9M Sep/2026
Medtronic 3.2B 141M Jun/2026
Orthofix International USD 130.35M 11.31M Dec/2025
Philips EUR 1.17B 33M Sep/2026
ResMed USD 290.65M 10.86M Jun/2026
Steris USD 366M 3.7M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 113.94M 2.3M Sep/2026
Teleflex USD 220.72M 7.21M Sep/2026
X T L Biopharmaceuticals USD 706K 50K Dec/2024
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026